Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Redmile Group just threw down $3.43 million on Krystal Biotech's stock. Why is a biotech company the hottest ticket in town? And what could this mean for investors eyeing the next big thing in gene therapy?